UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
UK Biobank: открытый ресурс для выявления причин широкого спектра сложных заболеваний среднего и пожилого возраста
2015-03-31
SCID: 54.1/82rwwfzt
Discuss with AI
UK Biobankcomplex diseasesgenome-wide genotypingmultimodal imagingprospective cohort study
Figures from the paper
Abstract (AI)
Points• UK Biobank is a very large and detailed prospective study with over 500,000 participants aged 40-69 years when recruited in 2006-2010.• The study has collected and continues to collect extensive phenotypic and genotypic detail about its participants, including data from questionnaires, physical measures, sample assays, accelerometry, multimodal imaging, genome-wide genotyping and longitudinal follow-up for a wide range of health-related outcomes.• Wide consultation; input from scientific, management, legal, and ethical partners; and industrial-scale, centralised processes have been essential to the development of this resource.• UK Biobank is available for open access, without the need for collaboration, to any bona fide researcher who wishes to use it to conduct health-related research for the benefit of the public.The challenge of understanding the determinants of common life-threatening and disabling conditions is substantial.These conditions are typically caused by a combination of lifestyle, environmental, and genomic factors, with individually modest effects and complex interactions, the detection and quantification of which require studies with large numbers of disease cases.While retrospective case-control studies of particular diseases [1] or existing prospective studies of particular risk factors can help to address this challenge [2,3], a complementary approach is to establish large prospective cohorts designed to study a much wider range of known and novel risk factors for a wide range of diseases [4].Prospective studies can assess exposures before the onset and treatment of disease, diseases that are not readily investigated by
Key Findings
1
Its scale and breadth are designed to detect modest effects and complex interactions among lifestyle, environmental, and genomic determinants of common diseases.
2
The resource integrates extensive phenotypic, genotypic, imaging, accelerometry, assay, and longitudinal health-outcome data.
3
UK Biobank is a large prospective cohort of over 500,000 adults aged 40–69 years recruited between 2006 and 2010.
4
UK Biobank provides open access without requiring collaboration to bona fide researchers conducting health-related research for public benefit.
5
Wide consultation and centralized, industrial-scale processes were essential to developing the UK Biobank resource.
Research Object
UK Biobank (a large population-based prospective study cohort)
Research Subject
The relationships of lifestyle, environmental, and genomic factors with the causes and risks of a wide range of complex diseases and health-related outcomes in middle and old age
Publication Details
Publication Date
2015-03-31
Journal
Publisher
ISSN
Cited by
13878
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by12
Multi-omics approaches to disease2017
Reproducible brain-wide association studies require thousands of individuals2022
Analysis of shared heritability in common disorders of the brain2018
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease2016
The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions2020
FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare2025
Delta lake: high-performance ACID table storage over cloud object stores2020
Signatures of negative selection in the genetic architecture of human complex traits2018
Empowering biomedical discovery with AI agents2024
A Comprehensive Review on Synergy of Multi-Modal Data and AI Technologies in Medical Diagnosis2024
Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment2018
Metabolomic profiles predict individual multidisease outcomes2022